一项针对混合核心血管成像推荐意见和指南证据的系统评价。
A systematic review for the evidence of recommendations and guidelines in hybrid nuclear cardiovascular imaging.
机构信息
Department of Nuclear Medicine-Molecular Imaging, DMU SMART IMAGING, Hôpitaux Universitaires Paris-Saclay, AP-HP, CHU Bicêtre, Le Kremlin Bicetre, France.
School of Medicine, Université Paris-Saclay, Le Kremlin-Bicetre, France.
出版信息
Eur J Nucl Med Mol Imaging. 2024 Jul;51(8):2247-2259. doi: 10.1007/s00259-024-06597-x. Epub 2024 Jan 15.
OBJECTIVES
This study aimed to evaluate the level of evidence of expert recommendations and guidelines for clinical indications and procedurals in hybrid nuclear cardiovascular imaging.
METHODS
From inception to August 2023, a PubMed literature analysis of the latest version of guidelines for clinical hybrid cardiovascular imaging techniques including SPECT(/CT), PET(/CT), and PET(/MRI) was performed in two categories: (1) for clinical indications for all-in primary diagnosis; subgroup in prognosis and therapy evaluation; and for (2) imaging procedurals. We surveyed to what degree these followed a standard methodology to collect the data and provide levels of evidence, and for which topic systematic review evidence was executed.
RESULTS
A total of 76 guidelines, published between 2013 and 2023, were included. The evidence of guidelines was based on systematic reviews in 7.9% of cases, non-systematic reviews in 47.4% of cases, a mix of systematic and non-systematic reviews in 19.7%, and 25% of guidelines did not report any evidence. Search strategy was reported in 36.8% of cases. Strengths of recommendation were clearly reported in 25% of guidelines. The notion of external review was explicitly reported in 23.7% of cases. Finally, the support of a methodologist was reported in 11.8% of the included guidelines.
CONCLUSION
The use of evidence procedures for developing for evidence-based cardiovascular hybrid imaging recommendations and guidelines is currently suboptimal, highlighting the need for more standardized methodological procedures.
目的
本研究旨在评估在混合核心血管成像的临床适应证和程序方面,专家建议和指南的证据水平。
方法
从 2023 年 8 月起,对包括 SPECT(/CT)、PET(/CT)和 PET(/MRI)在内的最新版临床混合心血管成像技术指南进行了 Pubmed 文献分析,分为两类:(1)所有主要诊断的临床适应证;亚组用于预后和治疗评估;以及 (2)影像学程序。我们调查了这些指南在多大程度上遵循了收集数据和提供证据水平的标准方法,以及哪些主题执行了系统评价证据。
结果
共纳入 76 项指南,发表时间为 2013 年至 2023 年。指南的证据基础是系统评价的占 7.9%,非系统评价的占 47.4%,系统评价和非系统评价混合的占 19.7%,25%的指南没有报告任何证据。36.8%的病例报告了检索策略。25%的指南明确报告了推荐强度。23.7%的病例明确报告了外部审查的概念。最后,11.8%的纳入指南报告了方法学家的支持。
结论
目前,在制定基于证据的心血管混合成像建议和指南时,对证据程序的使用并不理想,这突出表明需要更标准化的方法学程序。